[SCHEDULE 13G/A] iRhythm Technologies, Inc SEC Filing
Capital Research Global Investors filed Amendment No.4 to a Schedule 13G/A reporting its holdings in iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). The filing states CRGI holds 1,506,864 shares, representing 4.7% of the 31,925,267 shares believed outstanding, with sole voting and dispositive power for that amount. The filing cites an event date of 06/30/2025 and is signed on 08/05/2025.
The filing describes CRGI as a division of Capital Research and Management Company and related investment management entities that provide services under the name "Capital Research Global Investors." The statement includes a certification that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Capital Research Global Investors ha presentato l'Emendamento No.4 al Schedule 13G/A relativo alle sue partecipazioni in iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). La comunicazione indica che CRGI detiene 1,506,864 azioni, pari al 4.7% delle 31,925,267 azioni ritenute in circolazione, con potere di voto e di disposizione esclusivo su tale ammontare. Il documento riporta la data dell'evento 06/30/2025 ed 猫 firmato in data 08/05/2025.
La dichiarazione descrive CRGI come una divisione di Capital Research and Management Company e di entit脿 correlate di gestione degli investimenti che operano sotto il nome "Capital Research Global Investors". Il documento include una certificazione secondo cui le azioni sono state acquisite e sono detenute nell'ordinario svolgimento dell'attivit脿 e non con l'intento di modificare o influenzare il controllo dell'emittente.
Capital Research Global Investors present贸 la Enmienda No.4 al Schedule 13G/A que informa sobre sus participaciones en iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). La presentaci贸n indica que CRGI posee 1,506,864 acciones, que representan el 4.7% de las 31,925,267 acciones que se cree est谩n en circulaci贸n, con poder de voto y de disposici贸n exclusivo sobre esa cantidad. El documento cita la fecha del evento 06/30/2025 y est谩 firmado el 08/05/2025.
La presentaci贸n describe a CRGI como una divisi贸n de Capital Research and Management Company y de entidades relacionadas de gesti贸n de inversiones que prestan servicios bajo el nombre "Capital Research Global Investors". La declaraci贸n incluye una certificaci贸n de que las acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor.
Capital Research Global Investors電� iRhythm Technologies, Inc.鞚� 歆�攵勳棎 甏�頃� Schedule 13G/A 靾橃爼靹�(Amendment No.4)毳� 鞝滌稖頄堨姷雼堧嫟 (Common Stock, CUSIP 450056106). 鞝滌稖靹滌棎電� CRGI臧� 1,506,864欤�毳� 氤挫湢頃橁碃 鞛堨溂氅� 鞚措姅 氚滍枆欤检嫕鞙茧 於旍爼霅橂姅 31,925,267欤�鞚� 鞎� 4.7%鞐� 頃措嫻頃橁碃, 頃措嫻 靾橂焿鞐� 雽�頃� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃橁碃 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊姅 靷贝鞚检瀽毳� 06/30/2025搿� 氚濏瀳瓿� 鞛堨溂氅�, 靹滊獏鞚检潃 08/05/2025鞛呺媹雼�.
頃措嫻 鞝滌稖靹滊姅 CRGI毳� Capital Research and Management Company鞚� 頃� 攵�氍戈臣 "Capital Research Global Investors"霛茧姅 氇呾弓鞙茧 靹滊箘鞀るゼ 鞝滉车頃橂姅 甏�霠� 韴瀽鞖挫毄 氩曥澑霌る 靹る獏頃╇媹雼�. 霕愴暅 欤检嫕鞚� 鞝曥儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 氚滍枆須岇偓鞚� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 氤挫湢霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Capital Research Global Investors a d茅pos茅 l'Amendement No.4 au Schedule 13G/A d茅clarant ses participations dans iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). Le d茅p么t indique que CRGI d茅tient 1,506,864 actions, repr茅sentant 4.7% des 31,925,267 actions estim茅es en circulation, avec le pouvoir exclusif de vote et de disposition sur ce montant. Le document fait 茅tat d'une date d'茅v茅nement du 06/30/2025 et est sign茅 le 08/05/2025.
Le d茅p么t d茅crit CRGI comme une division de Capital Research and Management Company et des entit茅s associ茅es de gestion d'investissements fournissant des services sous le nom "Capital Research Global Investors". La d茅claration inclut une certification indiquant que les actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Capital Research Global Investors hat Nachtrag Nr. 4 (Amendment No.4) zu einem Schedule 13G/A eingereicht, der seine Beteiligungen an iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106) meldet. Die Einreichung gibt an, dass CRGI 1,506,864 Aktien h盲lt, was 4.7% der gesch盲tzten 31,925,267 ausstehenden Aktien entspricht, und dass es an dieser Menge 眉ber alleiniges Stimm- und Verf眉gungsrecht verf眉gt. Die Einreichung nennt das Ereignisdatum 06/30/2025 und ist am 08/05/2025 unterzeichnet.
Die Erkl盲rung beschreibt CRGI als eine Sparte der Capital Research and Management Company und assoziierte Investment-Management-Einheiten, die unter dem Namen "Capital Research Global Investors" Dienstleistungen erbringen. Die Mitteilung enth盲lt eine Best盲tigung, dass die Aktien im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten werden und nicht zum Zweck, die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
- None.
- None.
Insights
TL;DR: CRGI reports a 4.7% passive stake (1,506,864 shares) in IRTC; below 5% threshold, limited governance impact.
The filing discloses a non-controlling position of 1,506,864 shares, representing 4.7% of the 31,925,267 shares believed outstanding. Voting and dispositive power are reported as sole for that exact amount, and the certification states the holdings are in the ordinary course of business and not intended to influence control. From an investment-analysis perspective, this is a notable institutional position but falls below common 5% thresholds that often trigger heightened investor scrutiny or additional disclosure obligations.
TL;DR: The filing confirms sole voting/dispositive power for 1,506,864 shares and certifies holdings not intended to influence issuer control.
The Schedule 13G/A clarifies the reporting person is Capital Research Global Investors, a division of Capital Research and Management Company and affiliated investment management entities, organized in Delaware. The report emphasizes a passive ownership stance with explicit certification that the stake was not acquired to change or influence company control. Given the 4.7% level, this position is material as an institutional holding but does not, by itself, indicate governance intentions or control actions disclosed in this filing.
Capital Research Global Investors ha presentato l'Emendamento No.4 al Schedule 13G/A relativo alle sue partecipazioni in iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). La comunicazione indica che CRGI detiene 1,506,864 azioni, pari al 4.7% delle 31,925,267 azioni ritenute in circolazione, con potere di voto e di disposizione esclusivo su tale ammontare. Il documento riporta la data dell'evento 06/30/2025 ed 猫 firmato in data 08/05/2025.
La dichiarazione descrive CRGI come una divisione di Capital Research and Management Company e di entit脿 correlate di gestione degli investimenti che operano sotto il nome "Capital Research Global Investors". Il documento include una certificazione secondo cui le azioni sono state acquisite e sono detenute nell'ordinario svolgimento dell'attivit脿 e non con l'intento di modificare o influenzare il controllo dell'emittente.
Capital Research Global Investors present贸 la Enmienda No.4 al Schedule 13G/A que informa sobre sus participaciones en iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). La presentaci贸n indica que CRGI posee 1,506,864 acciones, que representan el 4.7% de las 31,925,267 acciones que se cree est谩n en circulaci贸n, con poder de voto y de disposici贸n exclusivo sobre esa cantidad. El documento cita la fecha del evento 06/30/2025 y est谩 firmado el 08/05/2025.
La presentaci贸n describe a CRGI como una divisi贸n de Capital Research and Management Company y de entidades relacionadas de gesti贸n de inversiones que prestan servicios bajo el nombre "Capital Research Global Investors". La declaraci贸n incluye una certificaci贸n de que las acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control del emisor.
Capital Research Global Investors電� iRhythm Technologies, Inc.鞚� 歆�攵勳棎 甏�頃� Schedule 13G/A 靾橃爼靹�(Amendment No.4)毳� 鞝滌稖頄堨姷雼堧嫟 (Common Stock, CUSIP 450056106). 鞝滌稖靹滌棎電� CRGI臧� 1,506,864欤�毳� 氤挫湢頃橁碃 鞛堨溂氅� 鞚措姅 氚滍枆欤检嫕鞙茧 於旍爼霅橂姅 31,925,267欤�鞚� 鞎� 4.7%鞐� 頃措嫻頃橁碃, 頃措嫻 靾橂焿鞐� 雽�頃� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃橁碃 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊姅 靷贝鞚检瀽毳� 06/30/2025搿� 氚濏瀳瓿� 鞛堨溂氅�, 靹滊獏鞚检潃 08/05/2025鞛呺媹雼�.
頃措嫻 鞝滌稖靹滊姅 CRGI毳� Capital Research and Management Company鞚� 頃� 攵�氍戈臣 "Capital Research Global Investors"霛茧姅 氇呾弓鞙茧 靹滊箘鞀るゼ 鞝滉车頃橂姅 甏�霠� 韴瀽鞖挫毄 氩曥澑霌る 靹る獏頃╇媹雼�. 霕愴暅 欤检嫕鞚� 鞝曥儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 氚滍枆須岇偓鞚� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 氤挫湢霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Capital Research Global Investors a d茅pos茅 l'Amendement No.4 au Schedule 13G/A d茅clarant ses participations dans iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106). Le d茅p么t indique que CRGI d茅tient 1,506,864 actions, repr茅sentant 4.7% des 31,925,267 actions estim茅es en circulation, avec le pouvoir exclusif de vote et de disposition sur ce montant. Le document fait 茅tat d'une date d'茅v茅nement du 06/30/2025 et est sign茅 le 08/05/2025.
Le d茅p么t d茅crit CRGI comme une division de Capital Research and Management Company et des entit茅s associ茅es de gestion d'investissements fournissant des services sous le nom "Capital Research Global Investors". La d茅claration inclut une certification indiquant que les actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Capital Research Global Investors hat Nachtrag Nr. 4 (Amendment No.4) zu einem Schedule 13G/A eingereicht, der seine Beteiligungen an iRhythm Technologies, Inc. (Common Stock, CUSIP 450056106) meldet. Die Einreichung gibt an, dass CRGI 1,506,864 Aktien h盲lt, was 4.7% der gesch盲tzten 31,925,267 ausstehenden Aktien entspricht, und dass es an dieser Menge 眉ber alleiniges Stimm- und Verf眉gungsrecht verf眉gt. Die Einreichung nennt das Ereignisdatum 06/30/2025 und ist am 08/05/2025 unterzeichnet.
Die Erkl盲rung beschreibt CRGI als eine Sparte der Capital Research and Management Company und assoziierte Investment-Management-Einheiten, die unter dem Namen "Capital Research Global Investors" Dienstleistungen erbringen. Die Mitteilung enth盲lt eine Best盲tigung, dass die Aktien im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten werden und nicht zum Zweck, die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
FAQ
What ownership stake did Capital Research Global Investors report in iRhythm (IRTC)?
What type of SEC filing did Capital Research Global Investors submit for IRTC?
What date is listed as the event requiring the Schedule 13G filing?
Does the filing indicate voting or dispositive power over the reported shares?
Did Capital Research state whether the shares were acquired to influence control of iRhythm?
